乌龙制药(URGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

URGN 乌龙制药

交易中 02-27 15:52:18 EST

21.46

+0.28

+1.30%

最高21.71	最低20.55	成交量52.05万
今开21.13	昨收21.18	日振幅5.50%
总市值10.04亿	流通市值7.95亿	总股本4,681万
成交额1,105万	换手率1.41%	流通股本3,703万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"URGN","market":"US","secType":"STK","nameCN":"乌龙制药","latestPrice":21.455,"timestamp":1772225537000,"preClose":21.18,"halted":0,"volume":520498,"delay":0,"changeRate":0.01298394711992439,"floatShares":37033665,"shares":46808892,"eps":-3.460625,"marketStatus":"交易中","change":0.275,"latestTime":"02-27 15:52:18 EST","open":21.125,"high":21.71,"low":20.545,"amount":11049629.140088,"amplitude":0.055005,"askPrice":21.51,"askSize":542,"bidPrice":21.41,"bidSize":125,"shortable":3,"etf":0,"ttmEps":-3.460625,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772226000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1493870400000,"exchange":"NASDAQ","adjPreClose":21.18,"preHourTrading":{"tag":"盘前","latestPrice":21.1,"preClose":21.18,"latestTime":"09:22 EST","volume":1391,"amount":29181.642945000003,"timestamp":1772202128611,"change":-0.08,"changeRate":-0.003777,"amplitude":0.076959},"postHourTrading":{"tag":"盘后","latestPrice":22,"preClose":21.18,"latestTime":"19:46 EST","volume":14257,"amount":302574.15,"timestamp":1772153194815,"change":0.82,"changeRate":0.038716,"amplitude":0.038716},"volumeRatio":1.080202,"impliedVol":0.9248,"impliedVolPercentile":0.7012},"requestUrl":"/m/hq/s/URGN","defaultTab":"news","newsList":[{"id":"2611190612","title":"乌龙制药盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611190612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611190612?lang=zh_cn&edition=full","pubTime":"2026-02-13 23:30","pubTimestamp":1770996648,"startTime":"0","endTime":"0","summary":"北京时间2026年02月13日23时30分，乌龙制药股票出现异动，股价急速上涨5.05%。截至发稿，该股报21.23美元/股，成交量14.4054万股，换手率0.31%，振幅5.20%。乌龙制药股票所在的生物技术行业中，整体涨幅为1.83%。乌龙制药公司简介：乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602132330489541152a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602132330489541152a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["URGN","BK4139"],"gpt_icon":0},{"id":"2610949026","title":"乌龙制药盘中异动 股价大跌5.17%报20.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610949026","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610949026?lang=zh_cn&edition=full","pubTime":"2026-02-12 00:15","pubTimestamp":1770826516,"startTime":"0","endTime":"0","summary":"北京时间2026年02月12日00时15分，乌龙制药股票出现异动，股价大幅跳水5.17%。截至发稿，该股报20.55美元/股，成交量20.163万股，换手率0.43%，振幅6.09%。乌龙制药股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Quince Therapeutics, Inc.、Ernexa Therapeutics Inc C/Wts  04/02/2030、内克塔治疗涨幅较大，Pmgc Holdings Inc.、Quince Therapeutics, Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为2232.05%、596.07%、187.59%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Quince Therapeutics, Inc.、Ernexa Therapeutics Inc C/Wts  04/02/2030，振幅分别为49.15%、46.56%、45.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602120015179540c9e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602120015179540c9e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["URGN","BK4139"],"gpt_icon":0},{"id":"2606234042","title":"乌龙制药盘中异动 大幅跳水5.00%报19.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606234042","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606234042?lang=zh_cn&edition=full","pubTime":"2026-01-24 02:31","pubTimestamp":1769193110,"startTime":"0","endTime":"0","summary":"北京时间2026年01月24日02时31分，乌龙制药股票出现波动，股价急速下跌5.00%。截至发稿，该股报19.00美元/股，成交量52.4726万股，换手率1.12%，振幅4.65%。机构评级方面，在所有8家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。乌龙制药股票所在的生物技术行业中，整体跌幅为0.86%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124023150953e2117&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124023150953e2117&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","URGN"],"gpt_icon":0},{"id":"2588040276","title":"乌龙制药盘中异动 早盘快速下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588040276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588040276?lang=zh_cn&edition=full","pubTime":"2025-12-03 00:21","pubTimestamp":1764692485,"startTime":"0","endTime":"0","summary":"北京时间2025年12月03日00时21分，乌龙制药股票出现异动，股价快速下跌5.15%。截至发稿，该股报27.00美元/股，成交量23.7525万股，换手率0.51%，振幅5.94%。机构评级方面，在所有8家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。乌龙制药股票所在的生物技术行业中，整体跌幅为0.15%。乌龙制药公司简介：乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120300212595270fb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120300212595270fb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["URGN","BK4139"],"gpt_icon":0},{"id":"2586260552","title":"乌龙制药盘中异动 下午盘大幅上涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586260552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586260552?lang=zh_cn&edition=full","pubTime":"2025-11-27 02:24","pubTimestamp":1764181471,"startTime":"0","endTime":"0","summary":"北京时间2025年11月27日02时24分，乌龙制药股票出现波动，股价急速上涨5.24%。截至发稿，该股报29.14美元/股，成交量52.6888万股，换手率1.13%，振幅6.86%。机构评级方面，在所有8家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。乌龙制药股票所在的生物技术行业中，整体涨幅为0.33%。乌龙制药公司简介：乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127022431951c19bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127022431951c19bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["URGN","BK4139"],"gpt_icon":0},{"id":"1111288030","title":"异动解读 | 乌龙制药夜盘暴跌8.16%，市场或担忧新药审批进度","url":"https://stock-news.laohu8.com/highlight/detail?id=1111288030","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111288030?lang=zh_cn&edition=full","pubTime":"2025-11-07 09:46","pubTimestamp":1762479975,"startTime":"0","endTime":"0","summary":"周四夜盘，乌龙制药股价大跌8.16%，引发市场关注。尽管公司近期召开的2025财年第三季度业绩会议传递出积极信号，但投资者似乎对公司部分产品的发展进度存在担忧。根据公司财报会议内容，乌龙制药目前现金储备超过1.27亿美元，管理层表示这足以支持公司运营直至盈利。管理层预计UGN-103将在2026年提交监管申请，2027年获得FDA批准。但FDA批准需要约12个月的随访数据，这一时间跨度可能超出了部分投资者的预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["URGN"],"gpt_icon":0},{"id":"1136329193","title":"UroGen 2025财年Q3业绩会总结及问答精华：现金储备与新药进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1136329193","media":"业绩会速递","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136329193?lang=zh_cn&edition=full","pubTime":"2025-11-07 00:06","pubTimestamp":1762445163,"startTime":"0","endTime":"0","summary":"UGN-103预计在2026年提交监管申请，2027年获得FDA批准。UGN-501预计在2026年启动一期临床试验。回答：预计2026年患者注册表格到收入确认的时间将与Jelmyto一致。UGN-103的FDA批准需要约12个月的随访数据，存在一定的不确定性。UroGen在2025财年Q3业绩会上展示了稳健的财务状况和积极的未来展望。现金储备充足，预计足以支持公司运营直至盈利。Zasturi和Jelmyto的市场推广进展顺利，社区医生的比例预计在2026年逐步增加。UGN-103和UGN-501的研发进展也为公司未来增长提供了坚实的基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["URGN"],"gpt_icon":0},{"id":"2581674222","title":"乌龙制药盘中异动 临近收盘急速下跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581674222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581674222?lang=zh_cn&edition=full","pubTime":"2025-11-05 04:41","pubTimestamp":1762288873,"startTime":"0","endTime":"0","summary":"北京时间2025年11月05日04时41分，乌龙制药股票出现波动，股价大幅下挫5.16%。截至发稿，该股报19.56美元/股，成交量67.1411万股，换手率1.45%，振幅4.46%。乌龙制药股票所在的生物技术行业中，整体跌幅为0.58%。乌龙制药公司简介：乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的解决方案。其收入来自产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105044113a6e13c4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105044113a6e13c4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["URGN","BK4139"],"gpt_icon":0},{"id":"1101397399","title":"乌龙制药宣布根据纳斯达克上市规则进行诱导性股权激励授予","url":"https://stock-news.laohu8.com/highlight/detail?id=1101397399","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101397399?lang=zh_cn&edition=full","pubTime":"2025-09-08 20:22","pubTimestamp":1757334151,"startTime":"0","endTime":"0","summary":"乌龙制药(Urogen Pharma Ltd.)宣布根据纳斯达克上市规则5635(C)(4)进行诱导性股权激励授予。\n该公司按照相关规定实施了这一股权激励计划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","URGN"],"gpt_icon":0},{"id":"2565816586","title":"乌龙制药盘中异动 大幅跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565816586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565816586?lang=zh_cn&edition=full","pubTime":"2025-09-05 00:17","pubTimestamp":1757002628,"startTime":"0","endTime":"0","summary":"北京时间2025年09月05日00时17分，乌龙制药股票出现波动，股价急速跳水5.01%。截至发稿，该股报18.40美元/股，成交量70.0022万股，换手率1.51%，振幅5.32%。机构评级方面，在所有8家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。乌龙制药股票所在的生物技术行业中，整体跌幅为0.06%。乌龙制药公司简介：乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250905001708a4b44e85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250905001708a4b44e85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","URGN"],"gpt_icon":0},{"id":"1158632186","title":"UroGen Pharma 2024年第四季度GAAP每股收益$(0.80) 未达$(0.68)预期，销售额$24.57M 未达$25.63M预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1158632186","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158632186?lang=zh_cn&edition=full","pubTime":"2025-03-10 20:04","pubTimestamp":1741608277,"startTime":"0","endTime":"0","summary":"UroGen Pharma  报告季度每股亏损$，比分析师一致预期的$低17.65%。与去年同期销售额$23.53百万相比，这是增长了4.40%。以上内容来自Benzinga Earnings专栏，原文如下：UroGen Pharma  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 17.65 percent. This is a 11.11 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $24.57 million which missed the analyst consensus estimate of $25.63 million by 4.17 percent.  This is a 4.40 percent increase over sales of","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"UroGen Pharma 2024年第四季度GAAP每股收益$(0.80) 未达$(0.68)预期，销售额$24.57M 未达$25.63M预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["URGN"],"gpt_icon":0},{"id":"2517416679","title":"乌龙制药盘中异动 早盘急速上涨5.00%报10.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517416679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517416679?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:04","pubTimestamp":1741190695,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时04分，乌龙制药股票出现异动，股价快速拉升5.00%。截至发稿，该股报10.08美元/股，成交量6.0004万股，换手率0.14%，振幅4.27%。机构评级方面，在所有7家参与评级的机构中，86%的券商给予买入建议，14%的券商给予持有建议，无券商给予卖出建议。乌龙制药股票所在的生物技术行业中，整体涨幅为1.34%。乌龙制药公司简介：乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的创新解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306000455abe9cdc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306000455abe9cdc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","URGN"],"gpt_icon":0},{"id":"2513907778","title":"乌龙制药盘中异动 早盘股价大跌5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513907778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513907778?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:20","pubTimestamp":1740410445,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时20分，乌龙制药股票出现异动，股价大幅跳水5.65%。截至发稿，该股报9.51美元/股，成交量11.31万股，换手率0.27%，振幅6.45%。机构评级方面，在所有7家参与评级的机构中，86%的券商给予买入建议，14%的券商给予持有建议，无券商给予卖出建议。乌龙制药股票所在的生物技术行业中，整体涨幅为0.55%。乌龙制药公司简介：乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的创新解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224232045abdb19c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224232045abdb19c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","URGN"],"gpt_icon":0},{"id":"2513124942","title":"乌龙制药盘中异动 临近收盘快速跳水5.14%报10.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513124942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513124942?lang=zh_cn&edition=full","pubTime":"2025-02-22 04:44","pubTimestamp":1740170644,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日04时44分，乌龙制药股票出现异动，股价大幅下跌5.14%。截至发稿，该股报10.16美元/股，成交量68.9788万股，换手率1.63%，振幅6.31%。最近的财报数据显示，该股实现营业收入25.20百万美元，净利润-23.67百万美元，每股收益-0.55美元，毛利22.75百万美元，市盈率-3.37倍。机构评级方面，在所有7家参与评级的机构中，86%的券商给予买入建议，14%的券商给予持有建议，无券商给予卖出建议。乌龙制药股票所在的生物技术行业中，整体涨幅为0.32%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222044405988e2ab5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222044405988e2ab5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["URGN","BK4139"],"gpt_icon":0},{"id":"2512487221","title":"Ladenburg Thalmann：假定UroGen Pharma(URGN.US)买入评级, 目标价31.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512487221","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512487221?lang=zh_cn&edition=full","pubTime":"2025-02-20 01:21","pubTimestamp":1739985687,"startTime":"0","endTime":"0","summary":"Ladenburg Thalmann：假定UroGen Pharma(URGN.US)买入评级, 目标价31.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/20012148268178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["URGN"],"gpt_icon":0},{"id":"2512484844","title":"乌龙制药盘中异动 早盘大幅上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512484844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512484844?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:23","pubTimestamp":1739982200,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时23分，乌龙制药股票出现异动，股价大幅拉升5.02%。截至发稿，该股报11.09美元/股，成交量8.3168万股，换手率0.20%，振幅4.35%。乌龙制药股票所在的生物技术行业中，整体涨幅为0.45%。乌龙制药公司简介：乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的创新解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220002321988b434b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220002321988b434b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["URGN","BK4139"],"gpt_icon":0},{"id":"2510334547","title":"乌龙制药盘中异动 临近午盘股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510334547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510334547?lang=zh_cn&edition=full","pubTime":"2025-02-12 00:43","pubTimestamp":1739292225,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日00时43分，乌龙制药股票出现波动，股价大幅下挫5.17%。截至发稿，该股报10.18美元/股，成交量17.5784万股，换手率0.42%，振幅5.22%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。乌龙制药股票所在的生物技术行业中，整体跌幅为1.43%。乌龙制药公司简介：乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的创新解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212004346abcb22c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212004346abcb22c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","URGN"],"gpt_icon":0},{"id":"2509209011","title":"乌龙制药盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509209011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509209011?lang=zh_cn&edition=full","pubTime":"2025-02-07 01:08","pubTimestamp":1738861737,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日01时08分，乌龙制药股票出现波动，股价大幅下挫5.15%。截至发稿，该股报11.04美元/股，成交量14.4508万股，换手率0.34%，振幅4.81%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。乌龙制药股票所在的生物技术行业中，整体跌幅为0.29%。乌龙制药公司简介：乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的创新解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207010857961a3103&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207010857961a3103&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","URGN"],"gpt_icon":0},{"id":"2509237068","title":"乌龙制药盘中异动 下午盘快速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509237068","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509237068?lang=zh_cn&edition=full","pubTime":"2025-02-06 02:37","pubTimestamp":1738780627,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日02时37分，乌龙制药股票出现波动，股价急速拉升5.04%。截至发稿，该股报11.87美元/股，成交量10.5532万股，换手率0.25%，振幅5.00%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。乌龙制药股票所在的生物技术行业中，整体涨幅为2.22%。乌龙制药公司简介：乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的创新解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206023707abc3b0f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206023707abc3b0f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","URGN"],"gpt_icon":0},{"id":"2507901677","title":"乌龙制药盘中异动 急速上涨5.27%报11.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507901677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507901677?lang=zh_cn&edition=full","pubTime":"2025-01-31 03:58","pubTimestamp":1738267114,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日03时58分，乌龙制药股票出现波动，股价急速上涨5.27%。截至发稿，该股报11.59美元/股，成交量15.3905万股，换手率0.36%，振幅5.22%。机构评级方面，在所有7家参与评级的机构中，86%的券商给予买入建议，14%的券商给予持有建议，无券商给予卖出建议。乌龙制药股票所在的生物技术行业中，整体涨幅为0.22%。乌龙制药公司简介：乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的创新解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131035835abbd8424&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131035835abbd8424&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["URGN","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.urogen.com","stockEarnings":[{"period":"1week","weight":-0.0284},{"period":"1month","weight":-0.0307},{"period":"3month","weight":-0.2648},{"period":"6month","weight":0.0889},{"period":"1year","weight":1.2628},{"period":"ytd","weight":-0.0956}],"compareEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":-0.0089},{"period":"3month","weight":0.0086},{"period":"6month","weight":0.0686},{"period":"1year","weight":0.1594},{"period":"ytd","weight":0.0108}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"乌龙制药有限公司于2004年4月以以色列国法律成立，名称为TheraCoat Ltd.，2015年9月，该公司更名为乌龙制药有限公司。该公司是一家临床阶段的生物制药公司，专注于开发旨在改变泌尿系统病理学护理标准的新型疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.032111},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.037057},{"month":3,"riseRate":0.375,"avgChangeRate":-0.010399},{"month":4,"riseRate":0.5,"avgChangeRate":0.047834},{"month":5,"riseRate":0.25,"avgChangeRate":-0.135298},{"month":6,"riseRate":0.777778,"avgChangeRate":0.327988},{"month":7,"riseRate":0.444444,"avgChangeRate":0.12723},{"month":8,"riseRate":0.555556,"avgChangeRate":0.030454},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.046538},{"month":10,"riseRate":0.555556,"avgChangeRate":0.023022},{"month":11,"riseRate":0.666667,"avgChangeRate":0.096296},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.074086}],"exchange":"NASDAQ","name":"乌龙制药","nameEN":"Urogen Pharma Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"乌龙制药(URGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供乌龙制药(URGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"乌龙制药,URGN,乌龙制药股票,乌龙制药股票老虎,乌龙制药股票老虎国际,乌龙制药行情,乌龙制药股票行情,乌龙制药股价,乌龙制药股市,乌龙制药股票价格,乌龙制药股票交易,乌龙制药股票购买,乌龙制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"乌龙制药(URGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供乌龙制药(URGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}